tasosartan has been researched along with Hypertension in 7 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antane, M; Bagli, JF; Chen, J; Collini, MD; Ellingboe, JW; Hartupee, D; Park, CH; Quagliato, D; Schmid, J; Tanikella, T; White, V | 1 |
| Schieffer, B; Schmidt, B | 1 |
| de Champlain, J; Gradman, AH; Lacourcière, Y; Larochelle, P; Pool, JL; Smith, WB; Svetkey, L | 1 |
| Buckalew, V; Chrysant, SG; Mroczek, WJ; Neutel, JM; Ruff, DA; Weber, M | 1 |
| Cléroux, J; Lacourcière, Y; Rhéaume, C; Waib, PH | 1 |
| Abernethy, DR; Andrawis, NS; Battle, MM; Burghart, PH; Klamerus, KJ; Mayer, P; Neefe, L; Weinryb, I | 1 |
| Allikmets, K; Franken, A; Häss, G; Parik, T; Skards, J; Viigimaa, M | 1 |
1 review(s) available for tasosartan and Hypertension
| Article | Year |
|---|---|
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Growth Hormone; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Thromboxane A2 | 2003 |
5 trial(s) available for tasosartan and Hypertension
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Placebos; Pyrimidines; Tetrazoles | 1998 |
Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Tetrazoles; Treatment Outcome; United States | 1999 |
Effects of angiotensin antagonism with tasosartan on regional and systemic haemodynamics in hypertensive patients.
Topics: Adult; Angiotensin Receptor Antagonists; Blood Pressure; Double-Blind Method; Exercise Test; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Oxygen Consumption; Pyrimidines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vascular Resistance | 1998 |
A pharmacokinetic and pharmacodynamic study of the potential drug interaction between tasosartan and atenolol in patients with stage 1 and 2 essential hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Atenolol; Drug Synergism; Humans; Hypertension; Middle Aged; Pyrimidines; Single-Blind Method; Tetrazoles | 2000 |
Tasosartan and hydroclorothiazide as combination therapy in the treatment of severe essential hypertension: comparison with enalapril. Tasosartan Study Group.
Topics: Analysis of Variance; Angiotensin II; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Pyrimidines; Tetrazoles | 2000 |
1 other study(ies) available for tasosartan and Hypertension
| Article | Year |
|---|---|
Metabolites of the angiotensin II antagonist tasosartan: the importance of a second acidic group.
Topics: Administration, Oral; Adrenal Glands; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Heart Rate; Hypertension; In Vitro Techniques; Injections, Intravenous; Liver; Models, Molecular; Molecular Conformation; Pyridones; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Structure-Activity Relationship; Tetrazoles | 1998 |